Rio de Janeiro, Brazil

Sergio Teixeira Ferreira

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Northwestern University, Universidade Federal Do Rio De Janeiro. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergio Teixeira Ferreira. Retrieved from https://idiyas.com/inventor/sergio-teixeira-ferreira

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2003-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sergio Teixeira Ferreira: Patents in Alzheimer’s Disease and Amyloidosis

Introduction

Sergio Teixeira Ferreira is an inventor associated with Rio de Janeiro, Brazil. His work includes patent inventions focused on potential approaches to Alzheimer’s disease and amyloidosis. He is credited with 2 patents.

Latest Patents

One patent, “Compositions and Methods for Treating Alzheimer’s Disease,” describes antibodies targeting amyloid-beta (Aβ) oligomers and methods for their use in treating Alzheimer’s disease. It particularly presents neuronal expression of single-chain variable fragment (scFv) antibodies against Aβ oligomers as a therapeutic approach.

Another patent, “Methods for Inhibition and Dissolution of Amyloidoses by Administration of Compositions Comprising 2,4-Dinitrophenol,” concerns inhibiting the formation and development of amyloidoses and dissolving amyloid deposits in organisms. The supplied description also refers to diagnostic methods using aromatic and heteroaromatic compounds with at least one electron-withdrawing group.

Career Highlights

Ferreira’s listed institutional affiliations include Northwestern University and the Universidade Federal do Rio de Janeiro. The provided information does not specify his roles or dates of work at these institutions.

Collaborations

His listed collaborators include Paulo Roberto Ferreira Louzada, Jr. and Diana Jerusalinsky.

Conclusion

Sergio Teixeira Ferreira’s patent portfolio, as described here, centers on proposed therapeutic and diagnostic approaches to Alzheimer’s disease and amyloidosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…